Herborium Group's Second Quarter Sales Grows over 132%

Fort Lee, N.J. July 16, 2014  Herborium® Group, Inc. (OTC Pink:
HBRM),
 www.Herborium.com, a
Botanical Therapeutics® Company and the provider of unique
all  botanical medicinal products  (Botanical
Therapeutics®) that target dermatological problems such as acne,
and other health  and wellness concerns in the areas of sexual
performance as well as energy  depletion and stress,
 reports  that  its sales  for  the Second
Quarter of  2014  grew by 132 % in comparison to the same
period of 2013. This puts the present run rate for AcnEase® sales
for 2014 to exceed $1 million dollars.  .

During the first six months (ending 5/31/2014) of 2014, Herborium's sales increased 86% in comparison to the same six month period in 2013.  The Company's Gross Profit increased 2.5 fold and the loss from operations for the same period decreased 86%.  The Company continues its expansion of AcnEase® in French market and has also began penetrating Spanish and Spanish speaking markets  with a newly established  Spanish Website and related e-commerce strategy. The Company's Facebook following is approaching 10,000 people.

Herborium remains very optimistic about growing its business, sales and product awareness due to the steady growth of the AcnEase® brand as well as its three new products that have already generated interest and will enter the market this year.  The Company continues its efforts to decrease costs.   While still recognizing the expenses associated with developing and launching new products and the associated upfront costs.  Herborium continues to retire debt, thus increasing the Company's ability to raise outside funds at a reasonable cost.  There is a rising interest in Botanical Therapeutics® among consumers as well as both the financial and medical communities that can serve as a solid foundation for the company's promising future.     

These developments put the Company closer to executing the up listing plan announced in 2013.   

About Herborium Group, Inc.

Herborium Group, Inc., a botanical therapeutics® company that develops, license and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements).  The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage.  Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other problems. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, and www.acnease.com.

Safe Harbor Statement:  This release contains forward-looking statements with respect to the results of operations and business of Sunrise Consulting Group, Inc., which involves risks and uncertainties.  The Company's actual future results could materially differ from those discussed.   The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

CONTACT: Dr. Agnes P. Olszewski
         [e-mail]
         or
         [e-mail]